Oral delivery of plant-derived HIV-1 p24 antigen in low doses shows a superior priming effect in mice compared to high doses (Q42231366)

19 October 2017

Oral delivery of plant-derived HIV-1 p24 antigen in low doses shows a superior priming effect in mice compared to high doses (English)

1 reference

19 October 2017

3

David Hallengärd

1 reference

19 October 2017

Ingrid Lindh

1

1 reference

19 October 2017

Andreas Bråve

2

1 reference

19 October 2017

Ronza Hadad

4

1 reference

19 October 2017

Irina Kalbina

5

1 reference

19 October 2017

Åke Strid

6

1 reference

19 October 2017

Sören Andersson

7

1 reference

19 October 2017

language of work or name

English

0 references

publication date

12 March 2014

1 reference

19 October 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

19 October 2017

32

1 reference

19 October 2017

20

1 reference

19 October 2017

2288-2293

1 reference

Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review

19 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

The design and evaluation of HIV-1 vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

7 January 2021

Acute HIV-1 Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

Induction of CD8+ regulatory T cells protects macaques against SIV challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

Production of HIV-1 p24 protein in transgenic tobacco plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

Preserved antigenicity of HIV-1 p24 produced and purified in high yields from plants inoculated with a tobacco mosaic virus (TMV)-derived vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

HIV-1 p24-immunoglobulin fusion molecule: a new strategy for plant-based protein production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

Feeding of mice with Arabidopsis thaliana expressing the HIV-1 subtype C p24 antigen gives rise to systemic immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

Plastid transformation of high-biomass tobacco variety Maryland Mammoth for production of human immunodeficiency virus type 1 (HIV-1) p24 antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

Expression of HIV-1 antigens in plants as potential subunit vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

High-level expression of human immunodeficiency virus antigens from the tobacco and tomato plastid genomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

Production of the p24 capsid protein from HIV-1 subtype C in Arabidopsis thaliana and Daucus carota using an endoplasmic reticulum-directing SEKDEL sequence in protein expression constructs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

Immunogenicity of a novel, bivalent, plant-based oral vaccine against hepatitis B and human immunodeficiency viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

Immunogenicity of chloroplast-derived HIV-1 p24 and a p24-Nef fusion protein following subcutaneous and oral administration in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

A C-terminal signal prevents secretion of luminal ER proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

Oral immunization with hepatitis B surface antigen expressed in transgenic plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

Targeting of plant-derived vaccine antigens to immunoresponsive mucosal sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

Low-dose exposure and immunogenicity of transgenic maize expressing the Escherichia coli heat-labile toxin B subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

Immunogenicity in humans of an edible vaccine for hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.073

10.1016/J.VACCINE.2014.02.073

7 January 2021

Identifiers

DOI

1 reference

19 October 2017

1 reference